A novel diagnostic method of Raman spectroscopy for malignant pheochromocytoma/paraganglioma. Issue 103 (27th October 2016)

• Record Type: Journal Article
• Authors: Du, Yiqing; Huang, Zhixin; Wang, Lei; Huang, Liqing; Cao, Peilong; He, Dalin; zhang, Yue; Wu, Dapeng; Yang, Zhishang; Fan, Jinhai
• Is Part Of: RSC advances. Volume 6:Issue 103(2016)
• Page Start: 101178
• Page End: 101184
• Publication Date: 2016-10-27
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c6ra18312c
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : Raman spectroscopy, a potential tool in diagnosis of malignant pheochromocytoma/paraganglioma. Abstract : We evaluated the feasibility of Raman spectroscopy in the diagnosis of malignant pheochromocytoma/paraganglioma. Raman spectra were detected from pheochromocytoma/paraganglioma tissues using a Labram HR 800 RS, then principal component analysis and linear discriminant analysis were applied to prediction. There are 25 qualified patients, including 20 with benign pheochromocytoma/paraganglioma and 5 with malignant pheochromocytoma/paraganglioma. The spectra at 680, 733, 780, 847, 939, 993, 1049, 1121, 1170, 1222, 1268, 1314, 1370, 1433, 1487, 1615, 1757 cm −1 of benign and malignant pheochromocytoma/paraganglioma are significantly different, assigned to specific amino acids and DNA. Principal component analysis/linear discriminant analysis yielded a sensitivity of 80.0% and a specificity of 100.0% for diagnosing malignant pheochromocytoma/paraganglioma. Furthermore, we evaluated the malignant behavior of pheochromocytoma/paraganglioma by both Raman spectroscopy and PASS scale. By using a survival analysis, Raman spectroscopy became more efficient than PASS score. Finally, Raman spectroscopy has potential in the diagnosis of malignant pheochromocytoma/paraganglioma in clinical practice.